Finance
UBS Upgrades Bayer to Buy as Glyphosate Litigation Outlook Brightens
UBS has upgraded German conglomerate Bayer AG to a 'buy' rating with a €52 price target, citing significant progress in resolving long-standing glyphosate litigation. The shift signals growing institutional confidence that the legal overhang from the Monsanto acquisition may finally be receding.
March 16, 202637 views
Score0
Enjoyed this story? Share it! 👇
Advertisement
Related Stories
Finance
Rising Medicare Part B Premiums Forecast to Double Over Next Decade
1h ago
Finance
BMW Reports Strong Q4 2025 Performance with 5.4% Yield and Robust Cash Flow Outlook
1h ago
Finance
UK Government Moves to Limit Powers of Financial Services Watchdog
1h ago
Finance
Ituran’s Subscriber Growth and Cash Flow Resilience Drive 24 Percent Stock Surge
2h ago
Comments (0)
Sign in to leave a comment.
No comments yet. Be the first to share your thoughts!